Information Provided By: 
Fly News Breaks for November 9, 2015
AZN, ZSPH
Nov 9, 2015 | 06:07 EDT
JPMorgan analyst Cory Kasimov downgraded ZS Pharma (ZSPH) to Neutral saying a competing takeover bid to AstraZeneca's (AZN) is unlikely to emerge. The analyst raised his price target for shares to $90 from $75.
News For ZSPH;AZN From the Last 2 Days
AZN
Apr 23, 2024 | 11:16 EDT
Bearish flow noted in AstraZeneca with 3,362 puts trading, or 1.7x expected. Most active are 4/26 weekly 70 puts and May-24 70 calls, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 1.72, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 25th.
